C-MET Inhibitors as New Members of the NSCLC Treatment Armamentarium

ISSN Print: 2169-2718
ISSN Online: 2169-2726
www.scirp.net/journal/alc
E-mail: [email protected]

Citations

"C-MET Inhibitors as New Members of the NSCLC Treatment Armamentarium—A Pooled Analysis"
written by Susanne Reuther, Niccolo Bassani, Michael F. Murphy, Wolfram Dempke,
published by Advances in Lung Cancer, Vol.11 No.1, 2022

has been cited by the following article(s):

[1]	A review on recent advances in drugs for lung cancer treatment
	2023

[2]	Oncogene alterations in non-small cell lung cancer—have we MET a new target?
	Translational Lung …, 2022

Top

[1]	Advances in the selective c-MET kinase inhibitors: Application of fused [5,6]-Bicyclic nitrogen-containing cores for anticancer drug design European Journal of Medicinal Chemistry, 2025 DOI:10.1016/j.ejmech.2024.117177